Embargoed and Restricted Access
Reason: Under embargo until November 2018. After this date a copy can be supplied under Section 51 (2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library
Ghrelin receptor agonists as novel breast cancer therapeutics
thesisposted on 2017-11-13, 00:41 authored by CHEUK MAN CHERIE AU
The human cell studies and the live mouse studies are intended to provide the information that is needed to apply therapies to treat breast cancer patients, based on our novel discoveries. We believe that des-acyl ghrelin-like compounds will be novel breast cancer therapeutics while avoiding well-documented serious side effects, including joint pain, osteoporosis or endometrial cancer. Our findings could therefore improve the quality of life of women treated for breast cancer, improve compliance and improve survival.